Center for Cancer Nanotechnology Excellence
and Translation (CCNE-T)
Today, Intel's research efforts are expanding the boundaries of computing and communications technology. Intel's world-class research in silicon and advanced process technology and manufacturing has helped it to achieve and maintain its industry leadership position. Its microprocessor research, second to none in the industry, continues to advance the state of the art and extend Moore's Law.
Intel research and development is a decentralized worldwide network of researchers, scientists and engineers who are pioneering technology innovation and catalyzing cooperation within the computing and communications industry. With a network of over 7,000 technology professionals, Intel can focus on developing breakthroughs in a variety of areas, including silicon technology and manufacturing, microarchitecture and circuits, computing platforms, communications and networking, and software technology. For more than 30 years, the company's research and development activities have continually expanded the possibilities for enhancing people's lives. Intel is based in Santa Clara.
In a future world of proactive computing, billions of tiny, powerful, connected devices throughout the environment will anticipate people's needs and take appropriate action on their behalf. With the formation of Intel Research in 1999, Intel began funding research into the emerging and disruptive technologies required to translate this vision into reality. Intel has initiated several projects in support of proactive computing. A number of strategic research projects are being carried out internally, within Intel's research and development labs. These projects cover a broad range of disciplines, including MEMS, precision biology, ad hoc networks, extreme networked systems, ubiquitous computing, novel storage, live databases, statistical models, computational nanovision, robotics, machine learning, supply chain visualization, distraction-free systems, proactive healthcare, and ethnography. Key to the CCNE-TR is the Emerging Technologies Division that is leading the way to study methods to develop and commercialize "lab on a chip" techniques including antibody based detection platforms.